Abstract
Session presented on Thursday, September 25, 2014:
The goal of prenatal care is to optimize pregnancy outcomes. Women who use potentially dangerous substances while pregnant present a special concern because prenatal exposure can cause poor pregnancy outcomes including early childhood behavioral issues, and negative developmental outcomes. Specific effects of individual drugs are difficult to determine with multiple use. In addition, substance use is often accompanied by other risk factors including poverty, stress, depression and lack of social support. Furthermore, risk factors such as exposure to violence and poor nutrition also exist. Perinatal substance abuse has reached critical levels in recent years. Healthcare providers face the difficult challenge of identifying women who are in need of treatment and identifying accessible services for treatment. While screening should be initiated at the first prenatal visit many providers feel, uncomfortable processing this information. There is bias regarding which specific women should be screened for substance use and they are unsure of legal ramifications or how to refer for appropriate interventions. These inconsistencies are not the only barriers women face. There are also extrinsic barriers such as lack of transportation, homelessness, drug use itself, childcare and the lack of or inadequate health insurance. Positive maternal and improved neonatal outcomes have been documented when substance abuse treatment has been integrated with prenatal care. In Toledo, Ohio, there is no prenatal care clinic for substance using women. This project addresses integration of prenatal care and proposes a model, which will include substance treatment options, mental health services, prenatal care and collaboration with the neonatal abstinence syndrome program. In addition, collaboration with social services in the postpartum period for the mother, infant and families will also be addressed. The purpose of this project is to develop a model for coordination of a prenatal care clinic for substance using women. Development of this model is expected to decrease substance use in the antepartum period, decrease medical costs for the mother and infant and decrease use of protective services and foster care. Collaboration with the neonatal abstinence syndrome will encourage mother infant bonding and self-care over the long term.
Sigma Membership
Zeta Theta at-Large
Lead Author Affiliation
Frontier Nursing University, Versailles, Kentucky, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Neonatal Abstinence Syndrome, Substance Abuse, Prenatal
Recommended Citation
Francis, Barbara J., "A model for coordination of a prenatal care clinic for substance abusing pregnant women" (2024). Leadership. 3.
https://www.sigmarepository.org/leadership/2014/posters/3
Conference Name
Leadership Summit 2014
Conference Host
Sigma Theta Tau International
Conference Location
Indianapolis, Indiana, USA
Conference Year
2014
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
A model for coordination of a prenatal care clinic for substance abusing pregnant women
Indianapolis, Indiana, USA
Session presented on Thursday, September 25, 2014:
The goal of prenatal care is to optimize pregnancy outcomes. Women who use potentially dangerous substances while pregnant present a special concern because prenatal exposure can cause poor pregnancy outcomes including early childhood behavioral issues, and negative developmental outcomes. Specific effects of individual drugs are difficult to determine with multiple use. In addition, substance use is often accompanied by other risk factors including poverty, stress, depression and lack of social support. Furthermore, risk factors such as exposure to violence and poor nutrition also exist. Perinatal substance abuse has reached critical levels in recent years. Healthcare providers face the difficult challenge of identifying women who are in need of treatment and identifying accessible services for treatment. While screening should be initiated at the first prenatal visit many providers feel, uncomfortable processing this information. There is bias regarding which specific women should be screened for substance use and they are unsure of legal ramifications or how to refer for appropriate interventions. These inconsistencies are not the only barriers women face. There are also extrinsic barriers such as lack of transportation, homelessness, drug use itself, childcare and the lack of or inadequate health insurance. Positive maternal and improved neonatal outcomes have been documented when substance abuse treatment has been integrated with prenatal care. In Toledo, Ohio, there is no prenatal care clinic for substance using women. This project addresses integration of prenatal care and proposes a model, which will include substance treatment options, mental health services, prenatal care and collaboration with the neonatal abstinence syndrome program. In addition, collaboration with social services in the postpartum period for the mother, infant and families will also be addressed. The purpose of this project is to develop a model for coordination of a prenatal care clinic for substance using women. Development of this model is expected to decrease substance use in the antepartum period, decrease medical costs for the mother and infant and decrease use of protective services and foster care. Collaboration with the neonatal abstinence syndrome will encourage mother infant bonding and self-care over the long term.